ADVANCED DIAGNOSTICS

 Improving diagnostics begins with biofilm…​

 
 

Species Identified

Are your providers treating your wound for the right bacteria?

  • Not all bacteria respond to the same antibiotic, and most wounds have multiple bacterial species

  • Many doctors identify bacteria by culturing it in a petri dish, but this method can only grow 1% of all known bacteria.

  • We can use DNA sequencing to reveal over 50,000 species of bacteria and fungi.

More wounds close when bacteria & fungi are accurately identified

  • When we have identified the microbes responsible for the biofilm, we can target them with a customized, localized treatment.

  • In many cases, we can apply the treatment topically, avoiding many antibiotic side effects.

  • Treatments like this have been shown to have a profound positive effect on healing rates.

Adapted from Wolcott, et. al: Journal of Wound Care Volume 24, Number 5. May 2015 pp 189-203

Wounds close faster when they get customized biofilm treatment

  • Modern research has shown topical ABX treatment guided by DNA diagnostics to have a substantial impact reducing median time-to-closure in chronic wounds.

Adapted from Wolcott, et. al: Journal of Wound Care Volume 24, Number 5. May 2015 pp 189-203

When all bacteria & fungi in the wound are identified, it is possible to formulate a custom antibiotic gel containing all drugs needed for each microbe present.

 

 Advanced Imaging Technologies

How are you assessing tissue viability?

  • Now, with new tools you can:

    • See vascular and arterial insufficiency immediately.​

    • Identify microvascular O2 levels in wound and peri-wound immediately.

    • Assess debridement adequacy.

    • Assess surgical closure & graft viability immediately

 
 

 How do you objectively know all non-viable tissue has been removed?

  • Dead tissue can harbor & protect bacteria & biofilm

    • When non-viable tissue is not addressed, it can increase time to heal & lead to poorer prognoses

 

Guiding Treatment Decisions

  • Insurers like to see justification for treatments

  • Have you considered deploying technologies to aid in treatment?

 

Evidence suggests progress and diagnostics should be re-evaluated every 30 days

  • We constantly assess the need to revisit advanced diagnostics.  ​

  • What we can addchange, or enhance? ​

 

 Next Steps

  • Do you have patients who could benefit from new tools?

  • Let our staff give you a more in-depth overview and arrange demonstrations which you can use for your patients. ​